Andrés L. Echazarreta

Recomendaciones sobre Enfermedad Pulmonar Obstructiva Crónica y Riesgo Cardiovascular

Diego Federico Echazarreta, Walter Javier Mattarucco, Augusto Lavalle Cobo, MIGUEL ANGEL HOMINAL et autres

COPD is a common, preventable, and treatable disease, usually caused by significant exposure to harmful particles or gases and influenced by host factors. Cardiovascular disease (CVD) comprises a series of pathologies with common risk factors, such as coronary artery disease, heart failure …

El síndrome clínico del post-COVID: ¿cuán profundo es el daño?

Diego Federico Echazarreta, C. Caso, Mariano Maydana, Silvana Elizabeth Marquez et autres

Objectives: The objective of this research was to explore the initial and delayed symptoms after SARSCoV-2 infection, describe its impact and quantify the residual damage. Materials and methods: from July 1, 2020 to September 1, 2022, patients who had presented a positive …

mx, es, ar (code pays fourni par la source)

Delphi Consensus on Clinical Applications of GOLD 2023 Recommendations in COPD Management: How Aligned are Recommendations with Clinical Practice?

Antonio Anzueto, Mark E. Cohen, Andrés L. Echazarreta, Gehan Elassal et autres

The objective of this Delphi study was to understand and assess the level of consensus among respiratory experts on the clinical application of GOLD 2023 recommendations in management of patients with chronic obstructive pulmonary disease (COPD). The study comprised two online surveys …

us, gt, Égypte, br, mx, tr, co (code pays fourni par la source)

Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

Alvar G.N. Agustí, Gastón De Stéfano, Alberto Levi, Xavier Muñoz et autres

SARS-CoV-2 vaccines have been extremely effective in reducing the incidence of severe coronavirus disease 2019 (COVID-19) [1, 2], but effective and safe treatments for acute infection are still limited [3, 4]. An uncontrolled pulmonary inflammatory response to SARS-CoV-2 is considered a key …

es, ar (code pays fourni par la source)

Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data

Elena García Castillo, Tamara Alonso, Julio Ancochea, María Teresa Pastor Sanz et autres

In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading system for patients with COPD, creating 16 subgroups (1A-4D). As part of the COPD Cohorts Collaborative International Assessment (3CIA) initiative, we aim to compare the mortality prediction of …

es, us, at, mx, ca, nl, dk, gb, no, jp, ar, fr, ch (code pays fourni par la source)

Sex differences in COPD outcome in 5,355 women with COPD: A new analysis of the 3CIA study

Tamara Alonso, Elena García Castillo, Julio Ancochea, María Teresa Pastor Sanz et autres

There is partial evidence that COPD is expressed differently in women than in men, namely on symptoms, pulmonary function, exacerbations, comorbidities or prognosis. There is a need to improve the characterization of COPD in females. We obtained and pooled data of 17 …

es, us, at, ca, nl, dk, no, jp, ar, fr (code pays fourni par la source)

Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data

Elena García Castillo, Tamara Alonso, María Teresa Pastor Sanz, Juan Pablo de-Torres et autres

In 2019, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposed a clinical grading system for patients with chronic obstructive pulmonary disease (COPD) with 4 categories (A-D) based on symptoms and exacerbation history.As part of the COPD Cohorts Collaborative International Assessment …

es, at, us, mx, dk, gb, no, jp, ar, fr, ca, ch (code pays fourni par la source)

Prevalence of Alpha-1 antitrypsin deficiency in COPD patients in Argentina. The DAAT.AR study

Guillermo Menga, Mariano Fernández Acquier, Andrés L. Echazarreta, Patricia Beatriz Sorroche et autres

ar (code pays fourni par la source)

Sex differences between women and men with COPD: A new analysis of the 3CIA study

Tamara Alonso, Elena García Castillo, Julio Ancochea, María Teresa Pastor Sanz et autres

es, us, at, ca, nl, dk, no, jp, ar, fr (code pays fourni par la source)

Prevalencia de déficit de alfa-1 antitripsina en pacientes con EPOC en Argentina. Estudio DAAT.AR

Guillermo Menga, Mariano Fernández Acquier, Andrés L. Echazarreta, Patricia Beatriz Sorroche et autres

ar (code pays fourni par la source)

Risk charts of five-year mortality in COPD patients

Andreas Horner, Pere Almagro, Joan Bautista Soriano, Bernhard Kaiser et autres

Background: Different multidimensional grading systems have been used to predict mortality in COPD patients. However, some are with poor calibration or too complex for daily use. As part of the COPD Cohorts Collaborative International Assessment (3CIA) initiative, we aimed to develop a …

at, es, us, ch, dk, gb, no, jp, fr, ca (code pays fourni par la source)

External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

Pere Almagro, Pablo Martínez‐Camblor, Marc Miravitlles, Mónica Rodríguez‐Carballeira et autres

The CODEX index was developed and validated in patients hospitalized for COPD exacerbation to predict the risk of death and readmission within one year after discharge. Our study aimed to validate the CODEX index in a large external population of COPD patients …

es, us, at, mx, nl, dk, gb, no, jp, ar, fr, ca, ch (code pays fourni par la source)